Osimertinib mesylate (AZD9291 mesylate) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an appa rent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGF 1 * 1 g
Catalog # MDEXHY-15772A
Supplier: MEDCHEMEXPRESS
Frequently Bought Together